JP2017521374A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017521374A5 JP2017521374A5 JP2016569875A JP2016569875A JP2017521374A5 JP 2017521374 A5 JP2017521374 A5 JP 2017521374A5 JP 2016569875 A JP2016569875 A JP 2016569875A JP 2016569875 A JP2016569875 A JP 2016569875A JP 2017521374 A5 JP2017521374 A5 JP 2017521374A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- kidney
- inhibitors
- use according
- donor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462004239P | 2014-05-29 | 2014-05-29 | |
| US62/004,239 | 2014-05-29 | ||
| PCT/US2015/032499 WO2015183842A1 (en) | 2014-05-29 | 2015-05-27 | Methods and compositions for preventing ischemia reperfusion injury in organs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074549A Division JP2020128383A (ja) | 2014-05-29 | 2020-04-20 | 臓器の虚血再灌流傷害を予防するための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017521374A JP2017521374A (ja) | 2017-08-03 |
| JP2017521374A5 true JP2017521374A5 (https=) | 2018-06-28 |
Family
ID=53398201
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569875A Withdrawn JP2017521374A (ja) | 2014-05-29 | 2015-05-27 | 臓器の虚血再灌流傷害を予防するための方法及び組成物 |
| JP2020074549A Pending JP2020128383A (ja) | 2014-05-29 | 2020-04-20 | 臓器の虚血再灌流傷害を予防するための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074549A Pending JP2020128383A (ja) | 2014-05-29 | 2020-04-20 | 臓器の虚血再灌流傷害を予防するための方法及び組成物 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20170081665A1 (https=) |
| EP (2) | EP3149172B1 (https=) |
| JP (2) | JP2017521374A (https=) |
| KR (1) | KR20170007492A (https=) |
| CN (2) | CN106661579B (https=) |
| AU (1) | AU2015267160B2 (https=) |
| BR (1) | BR112016028009A2 (https=) |
| CA (1) | CA2949109A1 (https=) |
| DK (2) | DK3149172T3 (https=) |
| ES (2) | ES2683869T3 (https=) |
| HU (2) | HUE054226T2 (https=) |
| IL (2) | IL248912A0 (https=) |
| LT (2) | LT3149172T (https=) |
| MX (2) | MX373950B (https=) |
| PL (2) | PL3149172T3 (https=) |
| PT (2) | PT3149172T (https=) |
| SI (2) | SI3444349T1 (https=) |
| WO (1) | WO2015183842A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4035659A1 (en) | 2016-11-29 | 2022-08-03 | PureTech LYT, Inc. | Exosomes for delivery of therapeutic agents |
| US12091664B2 (en) | 2018-01-12 | 2024-09-17 | University Of Massachusetts | Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation |
| GB202016863D0 (en) * | 2020-10-23 | 2020-12-09 | Causeway Therapeutics Ltd | Microrna-29 compounds, compositions and uses in therapy |
| JP2024539149A (ja) * | 2021-12-22 | 2024-10-28 | エヌエー ヴァクシン インスティテュート | 虚血・再灌流障害を予防または治療するための組成物及びその用途 |
| KR20240154159A (ko) * | 2023-04-17 | 2024-10-25 | 재단법인 아산사회복지재단 | miR-223을 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 |
| CN118460648B (zh) * | 2024-07-10 | 2025-01-28 | 凯莱英医药集团（天津）股份有限公司 | 一种qpi-1002的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5861254A (en) | 1997-01-31 | 1999-01-19 | Nexstar Pharmaceuticals, Inc. | Flow cell SELEX |
| CA2104698A1 (en) | 1991-02-21 | 1992-08-22 | John J. Toole | Aptamers specific for biomolecules and methods of making |
| US5756291A (en) | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
| WO1994025591A1 (en) | 1993-04-29 | 1994-11-10 | Unilever N.V. | PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| NZ513487A (en) | 1999-01-29 | 2003-02-28 | Univ Illinois | The use of a P53 inhibitor for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| US6376190B1 (en) | 2000-09-22 | 2002-04-23 | Somalogic, Inc. | Modified SELEX processes without purified protein |
| US20060105975A1 (en) | 2004-04-19 | 2006-05-18 | Shannon Pendergrast | Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
| AU2005288522B2 (en) | 2004-09-28 | 2012-06-28 | Quark Pharmaceuticals, Inc. | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| EP1989307B1 (en) | 2006-02-08 | 2012-08-08 | Quark Pharmaceuticals, Inc. | NOVEL TANDEM siRNAS |
| US7910566B2 (en) * | 2006-03-09 | 2011-03-22 | Quark Pharmaceuticals Inc. | Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA |
| WO2009001359A2 (en) | 2007-06-27 | 2008-12-31 | Quark Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of pro-apoptotic genes |
| AU2008306455C1 (en) * | 2007-10-03 | 2014-04-17 | Quark Pharmaceuticals, Inc. | Novel siRNA structures |
| WO2009155504A2 (en) * | 2008-06-20 | 2009-12-23 | The Children's Medical Center Corporation | Methods for the modulation of angiogenesis |
| CN102458418B (zh) * | 2009-06-08 | 2015-09-16 | 夸克制药公司 | 一种寡核苷酸化合物的制药用途 |
| DK2504435T3 (da) | 2009-11-26 | 2019-12-09 | Quark Pharmaceuticals Inc | Sirna-forbindelser omfattende terminale substitutioner |
| WO2011084193A1 (en) | 2010-01-07 | 2011-07-14 | Quark Pharmaceuticals, Inc. | Oligonucleotide compounds comprising non-nucleotide overhangs |
| WO2011138966A1 (ja) | 2010-05-06 | 2011-11-10 | ダイヤニトリックス株式会社 | 微生物触媒を用いたアクリルアミドの製造方法 |
| EP2640394A4 (en) * | 2010-11-17 | 2015-02-25 | Univ North Carolina | PROTECTION OF KIDNEY TISSUE FROM ISCHEMIA BY THE INHIBITION OF PROLEVERATIVE KINASES CDK4 AND CDK6 |
| AU2011338682B2 (en) | 2010-12-06 | 2017-04-27 | Quark Pharmaceuticals, Inc. | Double stranded oligonucleotide compounds comprising threose modifications |
| US9176487B2 (en) * | 2011-10-24 | 2015-11-03 | Mayo Foundation For Medical Education And Research | Methods and materials for reducing the risk of infections |
| DK2895608T3 (en) * | 2012-09-12 | 2019-01-21 | Quark Pharmaceuticals Inc | DOUBLE-STRENGTHED OIGONUCLEOTIDE MOLECULES FOR P53 AND PROCEDURES FOR USING IT |
-
2015
- 2015-05-27 LT LTEP15729289.7T patent/LT3149172T/lt unknown
- 2015-05-27 AU AU2015267160A patent/AU2015267160B2/en not_active Expired - Fee Related
- 2015-05-27 CN CN201580041391.4A patent/CN106661579B/zh not_active Expired - Fee Related
- 2015-05-27 SI SI201531563T patent/SI3444349T1/sl unknown
- 2015-05-27 CA CA2949109A patent/CA2949109A1/en not_active Abandoned
- 2015-05-27 HU HUE18183735A patent/HUE054226T2/hu unknown
- 2015-05-27 ES ES15729289.7T patent/ES2683869T3/es active Active
- 2015-05-27 PT PT15729289T patent/PT3149172T/pt unknown
- 2015-05-27 PL PL15729289T patent/PL3149172T3/pl unknown
- 2015-05-27 LT LTEP18183735.2T patent/LT3444349T/lt unknown
- 2015-05-27 PT PT181837352T patent/PT3444349T/pt unknown
- 2015-05-27 MX MX2016015635A patent/MX373950B/es active IP Right Grant
- 2015-05-27 PL PL18183735T patent/PL3444349T3/pl unknown
- 2015-05-27 KR KR1020167037012A patent/KR20170007492A/ko not_active Withdrawn
- 2015-05-27 WO PCT/US2015/032499 patent/WO2015183842A1/en not_active Ceased
- 2015-05-27 BR BR112016028009A patent/BR112016028009A2/pt active Search and Examination
- 2015-05-27 DK DK15729289.7T patent/DK3149172T3/en active
- 2015-05-27 JP JP2016569875A patent/JP2017521374A/ja not_active Withdrawn
- 2015-05-27 CN CN202011264844.9A patent/CN112410336A/zh active Pending
- 2015-05-27 EP EP15729289.7A patent/EP3149172B1/en not_active Not-in-force
- 2015-05-27 DK DK18183735.2T patent/DK3444349T3/da active
- 2015-05-27 ES ES18183735T patent/ES2862185T3/es active Active
- 2015-05-27 HU HUE15729289A patent/HUE040092T2/hu unknown
- 2015-05-27 US US15/312,425 patent/US20170081665A1/en not_active Abandoned
- 2015-05-27 EP EP18183735.2A patent/EP3444349B1/en active Active
- 2015-05-27 SI SI201530342T patent/SI3149172T1/sl unknown
-
2016
- 2016-11-11 IL IL248912A patent/IL248912A0/en active IP Right Grant
- 2016-11-28 MX MX2020005794A patent/MX2020005794A/es unknown
-
2017
- 2017-07-14 US US15/650,297 patent/US9868953B2/en not_active Expired - Fee Related
- 2017-12-05 US US15/832,334 patent/US20180305696A1/en not_active Abandoned
-
2020
- 2020-04-20 JP JP2020074549A patent/JP2020128383A/ja active Pending
- 2020-10-19 IL IL278144A patent/IL278144B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017521374A5 (https=) | ||
| Wei et al. | Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment | |
| JP2019504112A5 (https=) | ||
| JP2020007350A5 (https=) | ||
| JP2014532072A5 (https=) | ||
| US9868953B2 (en) | Methods and compositions for preventing ischemia reperfusion injury in organs | |
| JP7291418B2 (ja) | Ｐｃｓｋ９を標的としたアンチセンス核酸 | |
| JP2019513384A5 (https=) | ||
| JPWO2020061177A5 (https=) | ||
| US20190071670A1 (en) | Methods Of Treatment For Alpha-1 Antitrypsin Deficiency | |
| Kanold et al. | Extracorporeal photochemotherapy for graft versus host disease in pediatric patients | |
| Li et al. | Modular assembled biomimetic nanobubbles for synergistic therapy of ischemic stroke via cascade modulation thrombo-inflammatory network | |
| ES2702578T3 (es) | Tratamiento de la inflamación dérmica crónica con norketotifeno | |
| WO2018214860A1 (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| JP6928611B2 (ja) | 組合せ | |
| US20220241339A1 (en) | Abcb5+ stem cell therapeutics for liver disease | |
| JP2023541214A (ja) | オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物 | |
| CN114787355A (zh) | 具有血脑屏障穿透能力的肽-核酸复合物及包含该肽-核酸复合物的组合物 | |
| CN113262226B (zh) | 利舒地尔在制备细菌感染治疗药物中的应用 | |
| CN108348539A (zh) | 用于治疗肿瘤的方法 | |
| Chen et al. | SAT-370 miR-466o-3p promotes podocyte injury through targeting WT1 | |
| EP4619020A1 (en) | Composition and method for prolong survival of transplant and recipient | |
| WO2024173624A1 (en) | Compositions and methods for the treatment of sepsis | |
| JP6865457B2 (ja) | ブタ肝障害モデル | |
| HK40068943A (en) | Peptide-nucleic acid complex having blood-brain barrier penetration ability and composition comprising same |